{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T15:42:13Z","timestamp":1768664533938,"version":"3.49.0"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.2169\/internalmedicine.5765-25","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:07:55Z","timestamp":1750874875000},"page":"269-273","source":"Crossref","is-referenced-by-count":1,"title":["5-Fluorouracil-Related Lactic Acidosis in a Patient with Colon Cancer"],"prefix":"10.2169","volume":"65","author":[{"given":"Yosuke","family":"Osawa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manami","family":"Kazaoka","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, International University of Health and Welfare Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Akita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Nemoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Ohtake","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zhao R, Han M, Lin S, et al. Adverse drug events associated with fluorouracil use in patients with metastatic colorectal cancer: a real-world pharmacovigilance study based on the FDA adverse event reporting system. Expert Opin Drug Saf 23: 1295-1307, 2024.","DOI":"10.1080\/14740338.2024.2380513"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Espinoza AM, Venook AP. Lactic acidosis and colon cancer: oncologic emergency? Clin Colorectal Cancer 10: 194-197, 2011.","DOI":"10.1016\/j.clcc.2011.03.020"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hara Y, Miyamoto Y, Hiyoshi Y, et al. Severe encephalopathy, lactic acidosis and hyperammonaemia with FOLFIRI plus aflibercept after two-stage hepatectomy: a case Report. In Vivo 33: 563-565, 2019.","DOI":"10.21873\/invivo.11511"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yeh KH, Cheng AL. High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy. Br J Cancer 75: 464-465, 1997.","DOI":"10.1038\/bjc.1997.79"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rosen A, van Kuilenburg A, Assmann B, Kuhlen M, Borkhardt A. Severe encephalopathy, lactic acidosis, vegetative instability and neuropathy with 5-fluorouracil treatment - pyrimidine degradation defect or beriberi? Case Rep Oncol 4: 371-376, 2011.","DOI":"10.1159\/000328803"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fukuda M, Nabeta M, Muta T, et al. Disturbance of consciousness due to hyperammonemia and lactic acidosis during mFOLFOX6 regimen: case report. Medicine (Baltimore) 99: e21743, 2020.","DOI":"10.1097\/MD.0000000000021743"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yeung EK, Copland MA, Gill S. Type B lactic acidosis from fluorouracil in fluorouracil, oxaliplatin and leucovorin treatment for carcinoma of the colon in a hemodialysis patient. Clin Kidney J 11: 786-787, 2018.","DOI":"10.1093\/ckj\/sfy012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lee TH, Le D. A rare case of severe lactic acidosis from 5-fluorouracil after mFOLFOX6 treatment in a patient with advanced gastric cancer. Case Rep Oncol 14: 545-549, 2021.","DOI":"10.1159\/000514296"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Koenig H, Patel A. Biochemical basis for fluorouracil neurotoxicity. The role of Krebs cycle inhibition by fluoroacetate. Arch Neurol 23: 155-160, 1970.","DOI":"10.1001\/archneur.1970.00480260061008"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pinedo HM, Peters GF. Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6: 1653-1664, 1988.","DOI":"10.1200\/JCO.1988.6.10.1653"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Harmon C, Robinson MW, Hand F, et al. Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis. Cancer Immunol Res 7: 335-346, 2019.","DOI":"10.1158\/2326-6066.CIR-18-0481"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ishibashi S, Nishimura H, Mizusawa H. 5-FU-induced acute leukoencephalopathy. Intern Med 43: 1009-1010, 2004.","DOI":"10.2169\/internalmedicine.43.1009"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pinedo DM, Shah-Khan F, Shah PC. Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin. J Clin Oncol 25: 5320-5321, 2007.","DOI":"10.1200\/JCO.2007.13.5954"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chu G, Salzman J. Hyperammonemia after capecitabine associated with occult impairment of the urea cycle. Cancer Med 8: 1996-2004, 2019.","DOI":"10.1002\/cam4.2036"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5765-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:33:37Z","timestamp":1768620817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5765-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5765-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"article-number":"5765-25"}}